Trial Profile
Production of Antibodies Against Tnf-alfa Blockers in Patients With Psoriasis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 14 Aug 2012 New trial record